BioCentury | Jan 13, 2017
Company News

Selten, Vivus deal

...questions to Vivus. Selten Pharma Inc. , San Carlos, Calif. Vivus Inc. (NASDAQ:VVUS), Campbell, Calif. Business: Cardiovascular Nora Weintraub Selten Pharma Inc. Vivus...
BioCentury | Aug 10, 2015
Emerging Company Profile

New tac for modifying PAH

...to a pending patent covering the use of tacrolimus for PAH. Companies and Institutions Mentioned Selten Pharma Inc....
...in end-stage pulmonary arterial hypertension." American Journal of Respiratory and Critical Care Medicine (2015) Sidebars Selten Pharma Inc....
Items per page:
1 - 2 of 2
BioCentury | Jan 13, 2017
Company News

Selten, Vivus deal

...questions to Vivus. Selten Pharma Inc. , San Carlos, Calif. Vivus Inc. (NASDAQ:VVUS), Campbell, Calif. Business: Cardiovascular Nora Weintraub Selten Pharma Inc. Vivus...
BioCentury | Aug 10, 2015
Emerging Company Profile

New tac for modifying PAH

...to a pending patent covering the use of tacrolimus for PAH. Companies and Institutions Mentioned Selten Pharma Inc....
...in end-stage pulmonary arterial hypertension." American Journal of Respiratory and Critical Care Medicine (2015) Sidebars Selten Pharma Inc....
Items per page:
1 - 2 of 2